The effects of iontophoresis and electroporation on transdermal delivery of buprenorphine from solutions and hydrogels

被引:39
作者
Fang, JY
Sung, KC
Wang, JJ
Chu, CC
Chen, KT
机构
[1] Chang Gung Univ, Grad Inst Nat Prod, Pharmaceut Lab, Tao Yuan, Taiwan
[2] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan
[3] Fdn Med Ctr, Tainan, Taiwan
关键词
D O I
10.1211/002235702760345392
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The in-vitro permeation of buprenorphine across skin was investigated to assess the effects of iontophoresis and electroporation on drug permeation from solutions as well as from hydrogels. lontophoresis (0.3 mA cm(-2)) increased the buprenorphine permeation from solution by a factor of 14.27 as compared with passive diffusion; the application of electroporation increased the buprenorphine permeation from solutions by a factor of 8.45. The permeation experiments using cellulose membrane and stratum corneum (SC)-stripped skin as permeation barriers suggested that the enhancement with iontophoresis was primarily due to strong electrophoretic drift of buprenorphine molecules, whereas the enhancement seen with electroporation was mainly attributed to the creation of transient aqueous pores in the SC layer. Application of high-voltage pulses followed by iontophoresis resulted in a shorter permeation onset time from both solutions and hydrogels as compared with iontophoresis or electroporation alone. The charge repulsion between buprenorphine and chitosan vehicles as well as the competition effects of counter-ions for carboxymethylcellulose (CMC)-based polymers may account for the different permeation rates under electrical field. This study demonstrates the feasibility of using hydrogels for delivery of buprenorphine under the application of iontophoresis or electroporation, separately or together.
引用
收藏
页码:1329 / 1337
页数:9
相关论文
共 22 条
[1]   Iontophoresis and electroporation: comparisons and contrasts [J].
Banga, AK ;
Bose, S ;
Ghosh, TK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 179 (01) :1-19
[2]   Electrically-assisted transdermal delivery of buprenorphine [J].
Bose, S ;
Ravis, WR ;
Lin, YJ ;
Zhang, L ;
Hofmann, GA ;
Banga, AK .
JOURNAL OF CONTROLLED RELEASE, 2001, 73 (2-3) :197-203
[3]   Evaluation of transdermal iontophoresis of enoxacin from polymer formulations: in vitro skin permeation and in vivo microdialysis using Wistar rat as an animal model [J].
Fang, JY ;
Hsu, LR ;
Huang, YB ;
Tsai, YH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 180 (02) :137-149
[4]   Clinical pharmacokinetics of transdermal opioids - Focus on transdermal fentanyl [J].
Grond, S ;
Radbruch, L ;
Lehmann, KA .
CLINICAL PHARMACOKINETICS, 2000, 38 (01) :59-89
[5]   THE INFLUENCE OF COSOLVENTS ON THE IN-VITRO PERCUTANEOUS PENETRATION OF DICLOFENAC SODIUM FROM A GEL SYSTEM [J].
HO, HO ;
HUANG, FC ;
SOKOLOSKI, TD ;
SHEU, MT .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (08) :636-642
[6]   Anionic gels as vehicles for electrically-modulated drug delivery .1. Solvent and drug transport phenomena [J].
Hsu, CS ;
Block, LH .
PHARMACEUTICAL RESEARCH, 1996, 13 (12) :1865-1870
[7]   Transdermal alniditan delivery by skin electroporation [J].
Jadoul, A ;
Lecouturier, N ;
Mesens, J ;
Caers, W ;
Preat, V .
JOURNAL OF CONTROLLED RELEASE, 1998, 54 (03) :265-272
[8]   Electrically enhanced transdermal delivery of domperidone [J].
Jadoul, A ;
Preat, V .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 154 (02) :229-234
[9]  
MAITANI Y, 1994, CHEM PHARM BULL, V42, P1297
[10]   Synergistic effect of enhancers for transdermal drug delivery [J].
Mitragotri, S .
PHARMACEUTICAL RESEARCH, 2000, 17 (11) :1354-1359